Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
A Randomized Phase II Study of Atezolizumab and A Randomized Phase II Study of Atezolizumab and Bevacizumab with Y90 TARE in Patients with Unresectable Hepatocellular Carcinoma (HCC), HCRN GI19-405
Sponsored by Hoosier Cancer Research Network, Inc.
Active
$112.9K Funding
6 People
External
Related Topics
cancer,
immunotherapy,
clinical trial,
hepatocellular carcinoma,
treatment
People
Junaid Arshad
Co-Investigator (COI)
Medicine
﹒Assistant Professor, Medicine - (Clinical Scholar Track)
Gregory Woodhead
Principal Investigator (PI)
Medical Imaging
﹒Assistant Professor
Gustavo Cornejo
(CD)
Senior VP Health Sciences
﹒Research Compliance Administrator II
Rachna Shroff
Co-Investigator (COI)
Medicine
﹒Professor
Umbreen Rozell
Co-Investigator (COI)
Medicine
﹒Assistant Clinical Professor, Medicine - (Clinical Series Track)
Hina Arif Tiwari
Co-Investigator (COI)
Pathology
﹒Professor
